title: Patterns of dementia treatment use in assisted living facilities: a cross-sectional study of 1975 demented residents.
abstract: OBJECTIVE
  To report the associated factors with the nonuse of cholinesterase-inhibitors and memantine in residents from assisted living (AL) facilities suffering from dementia.
  
  
  METHODS
  A cross-sectional study.
  
  
  METHODS
  The "Réseau de Recherche en Etablissement d'Hébergement pour Personnes Agées" (REHPA) network composed of 236 AL facilities in France.
  
  
  METHODS
  4896 residents randomly selected by birth date.
  
  
  METHODS
  A structured questionnaire was completed for each resident by the geriatricians of each AL facility. Demographics, medical history (including diagnosis of dementia), drugs (including specific dementia treatments), functional status and behavioral disturbances were collected. Multivariate linear regression analyses were performed.
  
  
  RESULTS
  Among the 1975 suffering from dementia, 49.1% were not specifically treated. The independent associated factors to the nonuse of dementia treatment were an institutional length of stay longer than 3 years (OR = 1.62; 95% CI: 1.31-2.02), a transfer from a hospital (OR = 1.68; 95% CI: 1.33-2.11) or another institution (OR = 2.06; 95% CI: 1.45-2.93) before admission, being diagnosed by a specialist other than neurologist (GP: OR = 3.90; 95% CI: 2.58-5.89) (psychiatrist: OR = 1.88; 95% CI: 1.26-2.81) (geriatrician: OR = 1.42; 95% CI:1.08-1.87), a concomitant antipsychotic treatment (OR = 1.44; 95% CI: 1.13-1.82), the absence of behavioral disturbances (OR = 1.51; 95% CI: 1.14-2.01), and a higher degree of disability (OR = 2.16; 95% CI: 1.59-2.92).
  
  
  CONCLUSIONS
  Nearly half of the dementia-affected residents were not specifically treated. The independent associated factors that have been identified in the study might bring light on the particular issues of dementia treatments in AL facilities.
authors: Gérontopôle de Toulouse, Department of Geriatric Medicine, Toulouse University Hospital, Toulouse, France.
authors: Nadège
authors: N
authors: Barro-Belaygues
authors: Gabor
authors: G
authors: Abellan van Kan
authors: Yves
authors: Y
authors: Rolland
authors: Fati
authors: F
authors: Nourhashemi
authors: Maria
authors: M
authors: Soto-Martin
authors: Sophie
authors: S
authors: Gillette-Guyonnet
authors: Bruno
authors: B
authors: Vellas
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D040561:Assisted Living Facilities; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D003704:Dementia / Q000188:drug therapy*; D015259:Dopamine Agents / Q000627:therapeutic use; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D008559:Memantine / Q000627:therapeutic use; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D012044:Regression Analysis; D011795:Surveys and Questionnaires
chemical_list: D002800:Cholinesterase Inhibitors; D015259:Dopamine Agents; D008559:Memantine